Find policies, billing codes, payers, states, and providers

HCPCS G0433: HIV-1/HIV-2 Antibody Screening by ELISA

HCPCS Level II code G0433 represents an ELISA-based screening test for antibodies to HIV-1 and/or HIV-2. This laboratory screening code is nationally relevant as HIV screening remains a public health priority for early detection and linkage to care. Use of G0433 supports standardized reporting and billing for HIV antibody screening performed with enzyme-linked immunosorbent assay techniques.

Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of coverage and billing context for G0433, clinical implications of ELISA-based HIV screening, and operational considerations for laboratories and outpatient sites. The publication covers typical sites of service, how the code maps to laboratory workflows, common modifiers used in practice (listed separately), and benchmarking elements where available.

The report summarizes national policy and payer considerations relevant to HIV screening with ELISA, explains how G0433 is used in clinical workflows, and outlines topics for revenue cycle teams and clinical managers to monitor, including documentation, specimen handling, and claims submission practices. Data not available in the input is noted where applicable.

Customize your policy alerts

Sign up for hcpcs G0433 policy alerts

Get alerted when payer policies referencing G0433 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

HCPCS Level II code G0433 describes infectious agent antibody detection by enzyme-linked immunosorbent assay (ELISA) technique for HIV-1 and/or HIV-2, screening. The service type is a laboratory screening test for HIV antibodies using ELISA methodology. The typical site of service is laboratory settings, hospital outpatient laboratories, community clinics, and other clinical sites that collect specimens for laboratory analysis.

Data not available in the input.

Explore openpayer tools

View all tools

Find policies, billing codes, payers, states, and providers

HCPCS G0433: HIV-1/HIV-2 Antibody Screening by ELISA

Customize your policy alerts

Sign up for hcpcs G0433 policy alerts

Get alerted when payer policies referencing G0433 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A 28-year-old sexually active patient presents to an outpatient primary care clinic requesting routine screening for HIV infection as part of annual preventive care. The clinician documents patient consent and orders an HIV screening test using an enzyme-linked immunosorbent assay (ELISA) capable of detecting antibodies to HIV-1 and HIV-2. A licensed laboratory phlebotomist draws venous blood, labels the specimen, and transports it to the clinical laboratory. The laboratory performs the screening antibody ELISA assay (G0433). If the ELISA is reactive, reflex confirmatory testing per local protocol (e.g., HIV-1/HIV-2 differentiation immunoassay or HIV RNA testing) is initiated and results are reported to the ordering clinician. Typical workflow includes specimen collection at the clinic (POS: outpatient office) or at a standalone laboratory/phlebotomy site, laboratory processing in a certified clinical laboratory, and result reporting to clinician and patient. Documentation includes reason for test, informed consent for HIV testing if required by state law, specimen source, test performed (G0433), and interpretation of results.

Coding Specifications

Modifier	Description	When to Use
`00`	Service furnished without a bilateral procedure indicator	Use when no bilateral modifier is applicable; rarely used for laboratory tests but listed as a default modifier option.
`26`	Professional component	Use when billing only the professional (interpretive) component of a test separate from the technical component.
`TC`	Technical component	Use when billing only the technical component (laboratory processing) of the test.
`52`	Reduced services	Use if the laboratory test was partially reduced or not fully performed but still reportable.
`53`	Discontinued procedure	Use if specimen collection or testing was started but discontinued prior to completion.
`59`	Data not provided in the input	Data not available in the input.
`QW`	CLIA-waived test performed in waived setting	Use when an HIV ELISA method is CLIA-waived and performed in a waived setting (applicable only if test meets CLIA-waived criteria).
`GQ`	Data not provided in the input	Data not available in the input.
`QK`	Advanced practice practitioner billing identification	Use when an advanced practice clinician (e.g., nurse practitioner) performs and bills under their identifier where required.
`QX`	Medicare requires modifier for supervising practitioner	Use when a clinical lab test supervision by certain practitioners requires identification (varies by payer).

Taxonomy Code	Specialty	Notes
`207Q00000X`	Family Medicine	Common ordering provider for routine HIV screening in ambulatory care.
`208D00000X`	General Internal Medicine	Frequently orders HIV screening during preventive visits and primary care encounters.
`208000000X`	Pathology/Laboratory Medicine	Oversees laboratory testing, quality, and result interpretation for `G0433`.
`363L00000X`	Phlebotomy Technician	Performs specimen collection for laboratory testing.
`207P00000X`	Obstetrics & Gynecology	Orders HIV screening for prenatal and reproductive health care visits.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z11.4`	Encounter for screening for human immunodeficiency virus [HIV]	Standard code for asymptomatic patients receiving routine HIV antibody screening such as `G0433`.
`Z20.6`	Contact with and (suspected) exposure to human immunodeficiency virus [HIV]	Used when patient has known exposure and requires HIV screening and follow-up.
`O98.7`	Maternal infectious and parasitic diseases classifiable elsewhere complicating pregnancy, childbirth and the puerperium (HIV)	Used for HIV screening in prenatal care contexts.
`R75`	Inconclusive laboratory evidence of human immunodeficiency virus [HIV]	Applied when initial screening is reactive but confirmatory testing is pending or indeterminate.
`B20`	Human immunodeficiency virus [HIV] disease	Relevant when screening is part of care for a patient with known HIV infection (e.g., monitoring or additional testing).

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36415`	Collection of venous blood by venipuncture	Performed immediately before `G0433` when blood specimen is required for the ELISA screening.
`86701`	Antibody; HIV-1, screening (enzyme immunoassay [EIA] or enzyme-linked immunosorbent assay [ELISA])	A CPT laboratory code that is clinically equivalent to `G0433` in some billing contexts; used by laboratories and payers that accept CPT coding for HIV screening.
`87389`	Infectious agent antigen detection by enzyme immunoassay, multiple-step method (e.g., HIV antigen/antibody combo)	Performed in workflows that include antigen/antibody combination testing; may be ordered alongside or instead of `G0433` depending on clinical protocol.
`87535`	Infectious agent detection by nucleic acid (e.g., HIV-1 RNA), amplified probe technique	Used for confirmatory testing or viral load quantification if `G0433` is reactive and further molecular testing is indicated.
`86703`	Antibody; HIV-2, confirmatory or supplemental test	Used when differentiation between HIV-1 and HIV-2 antibodies is required after an initial reactive `G0433` screen.

HCPCS G9490: Home Visit Assessment for Non-Homebound Patients

HCPCS-G0008-INFLUENZA-VACCINE-ADMINISTRATION

HCPCS G0008: Influenza Virus Vaccine Administration

HCPCS-G0009-PNEUMOCOCCAL-VACCINE-ADMINISTRATION

HCPCS G0009: Administration of Pneumococcal Vaccine

HCPCS-G0010-HEPATITIS-B-VACCINE-ADMINISTRATION

HCPCS G0010: Administration of Hepatitis B Vaccine

HCPCS-G0011-PREP-COUNSELING-HIV-RISK-REDUCTION-ADHERENCE

HCPCS G0011: Individual PrEP Counseling, HIV Risk Assessment

HCPCS-G0012-PRE-EXPOSURE-PROPHYLAXIS-INJECTION-HIV-PREVENTION

HCPCS G0012: Injection of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention

HCPCS-G0013-PREP-INDIVIDUAL-COUNSELING-HIV-RISK-REDUCTION

HCPCS G0013: Individual PrEP Counseling and HIV Risk Assessment

HCPCS-G0017-PSYCHOTHERAPY-CRISIS-FIRST-60-MINUTES-NON-OFFICE

HCPCS G0017: Psychotherapy for Crisis, First 60 Minutes

HCPCS-G0018-PSYCHOTHERAPY-CRISIS-ADDITIONAL-30-MINUTES-NON-OFFICE

HCPCS G0018: Psychotherapy for Crisis, Additional 30 Minutes

HCPCS-G0019-COMMUNITY-HEALTH-INTEGRATION-SDOH-CARE-COORDINATION

HCPCS G0019: Community Health Integration for Social Determinants of Health

Showing 1–10 of 1996

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Explore openpayer tools

View all tools

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Modifier	Description	When to Use
`00`	Service furnished without a bilateral procedure indicator	Use when no bilateral modifier is applicable; rarely used for laboratory tests but listed as a default modifier option.
`26`	Professional component	Use when billing only the professional (interpretive) component of a test separate from the technical component.
`TC`	Technical component	Use when billing only the technical component (laboratory processing) of the test.
`52`	Reduced services	Use if the laboratory test was partially reduced or not fully performed but still reportable.
`53`	Discontinued procedure	Use if specimen collection or testing was started but discontinued prior to completion.
`59`	Data not provided in the input	Data not available in the input.
`QW`	CLIA-waived test performed in waived setting	Use when an HIV ELISA method is CLIA-waived and performed in a waived setting (applicable only if test meets CLIA-waived criteria).
`GQ`	Data not provided in the input	Data not available in the input.
`QK`	Advanced practice practitioner billing identification	Use when an advanced practice clinician (e.g., nurse practitioner) performs and bills under their identifier where required.
`QX`	Medicare requires modifier for supervising practitioner	Use when a clinical lab test supervision by certain practitioners requires identification (varies by payer).

Taxonomy Code	Specialty	Notes
`207Q00000X`	Family Medicine	Common ordering provider for routine HIV screening in ambulatory care.
`208D00000X`	General Internal Medicine	Frequently orders HIV screening during preventive visits and primary care encounters.
`208000000X`	Pathology/Laboratory Medicine	Oversees laboratory testing, quality, and result interpretation for `G0433`.
`363L00000X`	Phlebotomy Technician	Performs specimen collection for laboratory testing.
`207P00000X`	Obstetrics & Gynecology	Orders HIV screening for prenatal and reproductive health care visits.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z11.4`	Encounter for screening for human immunodeficiency virus [HIV]	Standard code for asymptomatic patients receiving routine HIV antibody screening such as `G0433`.
`Z20.6`	Contact with and (suspected) exposure to human immunodeficiency virus [HIV]	Used when patient has known exposure and requires HIV screening and follow-up.
`O98.7`	Maternal infectious and parasitic diseases classifiable elsewhere complicating pregnancy, childbirth and the puerperium (HIV)	Used for HIV screening in prenatal care contexts.
`R75`	Inconclusive laboratory evidence of human immunodeficiency virus [HIV]	Applied when initial screening is reactive but confirmatory testing is pending or indeterminate.
`B20`	Human immunodeficiency virus [HIV] disease	Relevant when screening is part of care for a patient with known HIV infection (e.g., monitoring or additional testing).

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36415`	Collection of venous blood by venipuncture	Performed immediately before `G0433` when blood specimen is required for the ELISA screening.
`86701`	Antibody; HIV-1, screening (enzyme immunoassay [EIA] or enzyme-linked immunosorbent assay [ELISA])	A CPT laboratory code that is clinically equivalent to `G0433` in some billing contexts; used by laboratories and payers that accept CPT coding for HIV screening.
`87389`	Infectious agent antigen detection by enzyme immunoassay, multiple-step method (e.g., HIV antigen/antibody combo)	Performed in workflows that include antigen/antibody combination testing; may be ordered alongside or instead of `G0433` depending on clinical protocol.
`87535`	Infectious agent detection by nucleic acid (e.g., HIV-1 RNA), amplified probe technique	Used for confirmatory testing or viral load quantification if `G0433` is reactive and further molecular testing is indicated.
`86703`	Antibody; HIV-2, confirmatory or supplemental test	Used when differentiation between HIV-1 and HIV-2 antibodies is required after an initial reactive `G0433` screen.

HCPCS G9490: Home Visit Assessment for Non-Homebound Patients

HCPCS-G0008-INFLUENZA-VACCINE-ADMINISTRATION

HCPCS G0008: Influenza Virus Vaccine Administration

HCPCS-G0009-PNEUMOCOCCAL-VACCINE-ADMINISTRATION

HCPCS G0009: Administration of Pneumococcal Vaccine

HCPCS-G0010-HEPATITIS-B-VACCINE-ADMINISTRATION

HCPCS G0010: Administration of Hepatitis B Vaccine

HCPCS-G0011-PREP-COUNSELING-HIV-RISK-REDUCTION-ADHERENCE

HCPCS G0011: Individual PrEP Counseling, HIV Risk Assessment

HCPCS-G0012-PRE-EXPOSURE-PROPHYLAXIS-INJECTION-HIV-PREVENTION

HCPCS G0012: Injection of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention

HCPCS-G0013-PREP-INDIVIDUAL-COUNSELING-HIV-RISK-REDUCTION

HCPCS G0013: Individual PrEP Counseling and HIV Risk Assessment

HCPCS-G0017-PSYCHOTHERAPY-CRISIS-FIRST-60-MINUTES-NON-OFFICE

HCPCS G0017: Psychotherapy for Crisis, First 60 Minutes

HCPCS-G0018-PSYCHOTHERAPY-CRISIS-ADDITIONAL-30-MINUTES-NON-OFFICE

HCPCS G0018: Psychotherapy for Crisis, Additional 30 Minutes

HCPCS-G0019-COMMUNITY-HEALTH-INTEGRATION-SDOH-CARE-COORDINATION

HCPCS G0019: Community Health Integration for Social Determinants of Health

Showing 1–10 of 1996

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

OpenPayer

HCPCS G0433: HIV-1/HIV-2 Antibody Screening by ELISA

Sign up for hcpcs G0433 policy alerts

Billing Code Overview

OpenPayer

HCPCS G0433: HIV-1/HIV-2 Antibody Screening by ELISA

Sign up for hcpcs G0433 policy alerts

Billing Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References